Vibrant Beauty Show is organized by Praveg Communications Pvt.Ltd. in Ahmedabad from 18-20 December 2015. Vibrant Beauty Show is the biggest trade exhibition and Symposium in the state of Gujarat.
Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.
Vibrant Beauty Show is organized by Praveg Communications Pvt.Ltd. in Ahmedabad from 18-20 December 2015. Vibrant Beauty Show is the biggest trade exhibition and Symposium in the state of Gujarat.
Confirming links between gut bacteria and cardiovascular disease, researchers have demonstrated that targeting microbes in the gut may prevent heart disease brought on by nutrients contained in a diet rich in red meat, eggs and high-fat dairy products.
In a first, a research team has succeeded in producing 3D images showing oxygen and carbon dioxide transport in the lungs, thus providing hope for better treatment of respiratory diseases.
Daily magnesium intake may be beneficial in preventing pancreatic cancer, researchers from Indiana University (IU) have found.
Vices such as AIDS and drug addiction are against the Indian tradition and should be tackled effectively, Goa Governor Mridula Sinha said in her address on the eve of the state's Liberation Day.
With nearly 5.2 million medical injuries recorded each year in India, an Assam professor, who recently lost his wife due to "utter callousness" of doctors has begun spreading awareness about medical negligence which he claims has acquired "endemic proportions" in the country.
In a rare surgery, a 26-year-old youth saved his father's life by donating a portion of his liver in spite of having a different blood group, hospital officials said on Saturday.
Aurobindo Pharma Limited is pleased to announce that the company has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Methylprednisolone Sodium Succinate Injection USP, 40 mg/vial, 125 mg/vial, 500 mg/vial, and 2 g/vial.
The U.S. Food and Drug Administration approved Basaglar (insulin glargine injection), a long-acting human insulin analog to improve glycemic control in adult and pediatric patients with type 1 diabetes mellitus and in adults with type 2 diabetes mellitus. Basaglar is manufactured by Eli Lilly and Company in Indianapolis, Indiana.
The U.S. Food and Drug Administration approved Bridion (sugammadex) injection to reverse the effects of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide, which are used during certain types of surgery in adults. Bridion is marketed by Merck Sharp and Dohme Corp., a subsidiary of Merck and Company, Inc., based in Whitehouse Station, New Jersey.
[adsense:336x280:8701650588]